Cancer Immunotherapy: Promise and Pitfalls

Name: Cancer Immunotherapy: Promise and Pitfalls
Uploaded: 2018-05-23T00:00:00+00:00
Description: Oncologist David Oh speaks at the October 2017 Bay Area Breast Cancer Forum about key developments in immunotherapy like immune checkpoint inhibitors and T-cell therapies, plus its use in experimental approaches to breast cancer treatment.

Oncologist David Oh speaks at the October 2017 Bay Area Breast Cancer Forum about key developments in immunotherapy like immune checkpoint inhibitors and T-cell therapies, plus its use in experimental approaches to breast cancer treatment.

Published

May 23, 2018

Created by

Related Presenters

Hope S. Rugo, MD

Breast oncologist
Medical Director, Cancer Infusion Services

Medical oncologist

Related Videos

New Keys to Cancer Care: How 2023 Findings Impact Treatment Decisions

These four collaborative talks from UCSF and John Muir Health specialists shine a light on recent study results that should inform treatment planning for patients with a variety of GI, breast, lung and blood cancers.

Video

Integrative Approaches to Symptom Management for Cancer Patients

This presentation from a variety of UCSF specialists covers a range of practical topics, from how clinicians can easily meet the new DEA educational requirement for opioid use disorder to the current evidence on mindfulness meditation's ...

Video

Focused Cancer Updates: Neoadjuvant Therapy for Breast Cancer and Managing Immunotherapy Toxicity

An expert panel delivers news to inform therapy and monitoring decisions, including a look at how the I-SPY 2 trial is accelerating evaluation of promising agents in high-risk breast cancer.

Video

Advances in Breast Cancer Care: Individualized Screening, Treatments and Follow-Up

Karen Goodwin, DO, covers everything from how to answer patients’ questions on mammogram frequency to how to counsel them on breast cancer prevention.

Video

CAR T-Cells for Hematologic Malignancies and Beyond

In this data-drenched discussion, UCSF specialists review how CAR T-cells are being used in hematologic malignancies, including aggressive lymphoma and difficult-to-treat myeloma, as well as for solid tumors, and reveal what's on the horizon ...

Video

Better Cancer Care: Pearls From the Best Studies of 2022

Focusing on blood, breast and lung cancers, our specialists deliver exciting findings from the latest phase III trials.

Video

Cutting-Edge Approaches to Prostate and Breast Cancers: Reach the Right Decision for Each Patient

In this grand rounds presentation, you’ll learn the best risk assessment tools for prostate cancer patients, the latest surgical techniques, such as fluorescence imaging and high-intensity focused ultrasound, and tests that allow for matching ...